SARS DNA vaccine (Antigen Express)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSARS DNA vaccine (Antigen Express)

Drug Alias NameSARS vaccine - Antigen Express/GenerexCoronavirus vaccine (Antigen Express/Generex Biotechnology Corporation)Severe Acute Respiratory Syndrome vaccine - Antigen Express/Generex

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsSevere Acute Respiratory Syndrome

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAntigen Express Inc Generex Biotechnology Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGenerex Biotechnology Corp Antigen Express Inc

Active IndicationsN/A

Inactive IndicationsSevere Acute Respiratory Syndrome

Other Information

ATC CodeN/A